Deregulation of angiopoietin-like 4 slows ovarian cancer progression through vascular endothelial growth factor receptor 2 phosphorylation.

Wu, Yuxian; Gao, Jinghai; Liu, Xiaojun

Wu, Yuxian; Gao, Jinghai; Liu, Xiaojun.

Afiliação

Wu Y; Department of Obstetrics and Gynaecology, Changzheng Hospital, Naval Medical University, 415 Fengyang Road, Shanghai, 200003, China.
Gao J; Department of Obstetrics and Gynaecology, Changzheng Hospital, Naval Medical University, 415 Fengyang Road, Shanghai, 200003, China.
Liu X; Department of Obstetrics and Gynaecology, Changzheng Hospital, Naval Medical University, 415 Fengyang Road, Shanghai, 200003, China. liuxiaojun@smmu.edu.cn.

Cancer Cell Int ; 21(1): 171, 2021 Mar 16.

Article em En | MEDLINE | ID: mdl-33726754

Palavras-chave

Angiogenesis; Angiopoietin-Like 4; Ovarian cancer; Vascular endothelial growth factor receptor 2; Vascular endothelial-cadherin

Texto completo

Imprimir

XML

PubMed Links

Buscar no Google

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Tipo de estudo: Prognostic_studies Idioma: En Revista: Cancer Cell Int Ano de publicação: 2021 Tipo de documento: Article

Texto completo

Imprimir

XML

PubMed Links

Buscar no Google